Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus
暂无分享,去创建一个
Toshiki Maruyama | Yataro Horikawa | L. Cui | K. Hiramatsu | H. Neoh | J. Lian | Keiichi Hiramatsu | Akira Iwamoto | Longzhu Cui | Hui-min Neoh | Jian-Qi Lian | Y. Horikawa | A. Iwamoto | Toshiki Maruyama | Hui-min Neoh
[1] B. Berger-Bächi,et al. The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon , 1994, Journal of bacteriology.
[2] G. Bierbaum,et al. Morphological and Genetic Differences in Two Isogenic Staphylococcus aureus Strains with Decreased Susceptibilities to Vancomycin , 2003, Antimicrobial Agents and Chemotherapy.
[3] A. Tomasz,et al. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus , 1997, Journal of bacteriology.
[4] D. Williams,et al. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. , 1984, Annual review of microbiology.
[5] M. Kuroda,et al. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. , 2000, Biochemical and biophysical research communications.
[6] R. Verwer,et al. Oriented fragmentation of Escherichia coli sacculi by sonication , 1980, Journal of bacteriology.
[7] Paul H. Axelsen,et al. Simultaneous Recognition of a Carboxylate-Containing Ligand and an Intramolecular Surrogate Ligand in the Crystal Structure of an Asymmetric Vancomycin Dimer , 1997 .
[8] M. Lessing,et al. Vancomycin-resistant Staphylococcus aureus , 1998, The Lancet.
[9] F. Stylianopoulou,et al. Emergence of Vancomycin-Intermediate Staphylococcus aureus and S. sciuri, Greece , 2002, Emerging infectious diseases.
[10] K. Hiramatsu,et al. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. , 1998, The Journal of antimicrobial chemotherapy.
[11] Arjun Srinivasan,et al. Vancomycin Resistance in Staphylococci , 2002, Clinical Microbiology Reviews.
[12] S. Boyle-Vavra,et al. A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical Staphylococcus aureus Isolates , 2001, Antimicrobial Agents and Chemotherapy.
[13] M. Bischoff,et al. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance. , 2001, FEMS microbiology letters.
[14] A. Balows,et al. MRSA: current perspectives , 2004 .
[15] K. Hiramatsu,et al. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community , 2002, Current opinion in infectious diseases.
[16] L. Cui,et al. Isolation in Brazil of Nosocomial Staphylococcus aureus With Reduced Susceptibility to Vancomycin , 2001, Infection Control & Hospital Epidemiology.
[17] G. Archer,et al. Role of Penicillin-Binding Protein 4 in Expression of Vancomycin Resistance among Clinical Isolates of Oxacillin-ResistantStaphylococcus aureus , 2001, Antimicrobial Agents and Chemotherapy.
[18] R. Daum,et al. Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus , 1996, Antimicrobial agents and chemotherapy.
[19] K. Hiramatsu,et al. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. , 1998, The Journal of antimicrobial chemotherapy.
[20] J. Shetty,et al. Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus , 2003, Science.
[21] V. Singh,et al. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. , 2003, Microbiology.
[22] L. Cui,et al. Staphylococcus Aureus Resistance in Genes Associated with Glycopeptide Dna Microarray-based Identification of Supplemental Material , 2005 .
[23] G. Shockman,et al. NUTRITIONAL REQUIREMENTS FOR BACTERIAL CELL WALL SYNTHESIS , 1961, Journal of bacteriology.
[24] G. Edwards,et al. Vancomycin-intermediate Staphylococcus aureus at a Scottish Hospital , 2000 .
[25] O. Chesneau,et al. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. , 2000, The Journal of antimicrobial chemotherapy.
[26] C. Pai,et al. Vancomycin-Intermediate Staphylococcus aureus in Korea , 2000, Journal of Clinical Microbiology.
[27] C. Sanders,et al. Vancomycin concentration in human tissues--preliminary report. , 1979, The Journal of antimicrobial chemotherapy.
[28] N Woodford,et al. Vancomycin-resistant enterococci , 1993, The Lancet.
[29] F. Tenover,et al. Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus , 2003, Journal of Clinical Microbiology.
[30] E. Mongodin,et al. Microarray Transcription Analysis of Clinical Staphylococcus aureus Isolates Resistant to Vancomycin , 2003, Journal of bacteriology.
[31] B. Robinson-Dunn,et al. Emergence of Vancomycin Resistance inStaphylococcus aureus , 1999 .
[32] A. von Gottberg,et al. Emerging glycopeptide resistance in gram-positive organisms. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[33] C. Martín,et al. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital , 1998, The Lancet.
[34] Jang-Jih Lu,et al. Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureus , 2005, Journal of Clinical Microbiology.
[35] A. Tomasz,et al. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. , 1999, The New England journal of medicine.
[36] A. Tomasz,et al. Inactivated pbp4 in Highly Glycopeptide-resistant Laboratory Mutants of Staphylococcus aureus * , 1999, The Journal of Biological Chemistry.
[37] C. Gemmell. Glycopeptide resistance in Staphylococcus aureus: is it a real threat? , 2004, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[38] M. Kuroda,et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. , 2001, Trends in microbiology.
[39] S. Hori,et al. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP 2' production , 1996, Antimicrobial agents and chemotherapy.
[40] R. Paton,et al. Glycopeptide resistance in an epidemic strain of methicillin-resistant Staphylococcus aureus. , 2001, The Journal of antimicrobial chemotherapy.
[41] K. Bowker,et al. Vancomycin-resistant Staphylococcus aureus , 1998, The Lancet.
[42] M. Bischoff,et al. tcaA Inactivation Increases Glycopeptide Resistance in Staphylococcus aureus , 2004, Antimicrobial Agents and Chemotherapy.
[43] P. Fey,et al. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex , 1993, Antimicrobial Agents and Chemotherapy.
[44] M. Sugai,et al. Increased Glycan Chain Length Distribution and Decreased Susceptibility to Moenomycin in a Vancomycin-Resistant Staphylococcus aureus Mutant , 2002, Antimicrobial Agents and Chemotherapy.
[45] S. Cosgrove,et al. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. , 1997, MMWR. Morbidity and mortality weekly report.
[46] L. Cui,et al. Has vancomycin-resistant Staphylococcus aureus started going it alone? , 2004, The Lancet.
[47] R. Daum,et al. Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate , 1997, Journal of bacteriology.
[48] F. Tenover,et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. , 1997, The Journal of antimicrobial chemotherapy.
[49] G. Pugliese,et al. S aureus With Reduced Susceptibility to Vancomycin , 2000, Infection Control & Hospital Epidemiology.
[50] D. Williams,et al. An analysis of the origins of a cooperative binding energy of dimerization. , 1998, Science.
[51] K. Hiramatsu,et al. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[52] K. Hiramatsu. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. , 2001, The Lancet. Infectious diseases.
[53] H. Murakami,et al. Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomycin Resistance Expressed by Staphylococcus aureus Mu50 , 2000, Antimicrobial Agents and Chemotherapy.